Sponsor:University of California, San FranciscoBrief Summary: Photobiomodulation (PBM) describes the use of near-infrared light (which is not visible to the…
Sponsor:Eli Lilly and CompanyBrief Summary: The main purpose of this study is to evaluate the safety and tolerability of LY3372993…
Sponsor:New York State Psychiatric InstituteBrief Summary: This protocol focuses on novel measures of cognition and everyday function that have robust…
Sponsor:AriBio Co., Ltd.Brief Summary: A double-blinded, randomized, placebo-controlled study will be performed to evaluate the efficacy and safety of treating…
Sponsor:Avanir PharmaceuticalsBrief Summary: This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo,…
Sponsor:Eli Lilly and CompanyBrief Summary: The reason for this study is to see how safe and effective the study drug…
Sponsor:Eisai Inc.Brief Summary: This study will be conducted to evaluate the efficacy of BAN2401 in participants with early Alzheimer's disease…
Sponsor:Zhejiang Hisun Pharmaceutical Co. Ltd.Brief Summary: multi-center, randomized, double-blind, parallel-group,placebo-controlled study to evaluate the safety and tolerability, efficacy, and PK…
Sponsor:Eli Lilly and CompanyBrief Summary: The purpose of this study is to evaluate the safety, tolerability and efficacy of LY3002813…
Sponsor:University of California, San FranciscoBrief Summary: These caregivers are a vulnerable group due to their physical isolation and well-documented rural…
